In this interview we discuss the ASCO provisional clinical opinion on second-line hormonal therapy for chemotherapy-naive castration-resistant prostate cancer.
Eric Singer, MD
Advertisement
Articles by Eric Singer, MD
Advertisement
Latest Updated Articles
New ASCO Guideline on Second-Line Hormone Therapy in Prostate CancerPublished: July 26th 2017 | Updated:
Advertisement
Advertisement
Trending on CancerNetwork
1
Anti-TIGIT Combination Therapy Yields Positive Survival in Gastric Cancers
2
ESMO 2025: Key Anticipated Updates in Breast and Lung Tumors
3
Bridging Radiotherapy Prior to CAR T May Be Safe in R/R Multiple Myeloma
4
Translating CLL Trial Success to Real-World Treatment Application
5
